112 Results for "

SOS1

" in MedChemExpress (MCE) Product Catalog:
Products (112)

112 Results for "SOS1" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
Cat. No.: HY-184586
Target:  

SOS1 Ras p38 MAPK

Research Areas:  

Cancer

SOS1-IN-28 is an orally active, blood-brain barrier permeable SOS1 inhibitor with an IC50 value of 0.11 μM. SOS1-IN-28 disrupts the SOS1: KRAS protein-protein interaction, with an IC50 of 0.29 μM for the KRAS-RAF interaction. SOS1-IN-28 blocks GTP loading of KRAS, inhibits RAS-MAPK pathway activity, and reduces cancer cell proliferation. SOS1-IN-28 can be used for the research of KRAS G12C-mutant lung cancer [1].
loading...
    loading...
Cat. No.: HY-173341
CAS No.: 2224491-20-5
Target:  

Ras

Research Areas:  

Cancer

SOF-436 is a KRAS inhibitor that inhibits SOS1-mediated KRAS nucleotide exchange (IC50 = 60 μM) and the binding of KRAS to the effector protein RAF. SOF-436 can be used in cancer research [1].
loading...
    loading...
Cat. No.: HY-161637
CAS No.: 2633633-39-1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

E3 ligase Ligand 25 (part of Compd 1) is a ligand for E3 ligase, used for the synthesis of PROTAC SOS1 degrader (HY-161634) [1].
loading...
    loading...
Cat. No.: HY-161639
CAS No.: 2911613-35-7
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

E3 ligase Ligand 26 (part of Compd 10) is a ligand for E3 ligase, used for the synthesis of PROTAC SOS1 degrader (HY-161636) [1].
loading...
    loading...
Cat. No.: HY-161714
CAS No.: 2922069-42-7
Target:  

SOS1 Ras

Research Areas:  

Cancer

HH0043 (Compound 10f) is an orally active and potent SOS1 inhibitor, with IC50 value of 5.8 nM. HH0043 can be used for the research of cancer [1].
loading...
    loading...
Cat. No.: HY-161638
CAS No.: 2911613-56-2
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 108 is a E3 ligase ligand-linker conjugate, used for the the synthesis of PROTAC SOS1 degrader (HY-161634) [1].
loading...
    loading...
Cat. No.: HY-161640
CAS No.: 2911613-55-1
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 109 is a E3 ligase ligand-linker conjugate, used for the the synthesis of PROTAC SOS1 degrader (HY-161636) [1].
loading...
    loading...
Cat. No.: HY-P83568
Synonyms: alternate SOS1; GF1; GGF1; GINGF; gingival fibromatosis; HGF; NS4; SOS1

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-101796
CAS No.: 4551-00-2
Purity:  99.42%
Target:  

Ras SOS1

Research Areas:  

Cancer

NSC-70220 is a selective and allosteric SOS1 inhibitor. NSC-70220 inhibits allosteric site activation, and partially inhibited catalytic site activation. NSC-70220 has an anticancer effect [1].
loading...
    loading...
Cat. No.: HY-161657
Research Areas:  

Cancer

2-Methoxyphenyl dihydrouracil-azaspiro[5.5]undecane-C-PIP is an E3 Ligase ligand-linker conjugate, and can be used for synthesis of PROTAC SOS1 degrader-10 (HY-161654) [1].
loading...
    loading...
Cat. No.: HY-161656
CAS No.: 3027978-51-1
Target:  

PROTAC Linkers

Research Areas:  

Cancer

PIP-C-3-Azaspiro[5.5]undecane-boc is the linker for PROTAC. PIP-C-3-Azaspiro[5.5]undecane-boc is utilized for synthesis of PROTAC SOS1 degrader-10 (HY-161654) [1].
loading...
    loading...
Cat. No.: HY-151968
CAS No.: 2821863-70-9
Target:  

Ras

Research Areas:  

Cancer

KRAS G12C inhibitor 57 (Compound 50) is a potent, selective, covalent and orally active KRAS G12C inhibitor with an IC50 of 0.21 μM in KRAS G12C/SOS1 binding assay. KRAS G12C inhibitor 57 induces cancer cell apoptosis [1].
loading...
    loading...
Cat. No.: HY-175891
CAS No.: 2836274-72-5
Research Areas:  

Others

POI ligand-5 (Compound M8) is a SOS1 ligand that can be used to synthesize PROTACs, such as PROTAC SOS1 degrader-5 (HY-161173) [1].
loading...
    loading...
Cat. No.: HY-183365
Research Areas:  

Cancer

SL43 is an orally active and potent SOS1 inhibitor with a Kd of 0.16 μM. SL43 disrupts SOS1-KRAS interaction, inhibits SOS1-mediated nucleotide exchange on KRAS mutants, and suppresses RAS-MAPK signaling. SL43 exerts antiproliferative activity against KRAS-mutant cancer cells, induces early apoptosis and G1 phase cell cycle arrest, and reduces phosphorylated MEK and ERK levels. SL43 suppresses tumor growth in a colorectal cancer xenograft model [1].
loading...
    loading...
Cat. No.: HY-P704193
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SOS1; Son Of Sevenless Homolog 1 (Drosophila), Isoform CRA_d; Prev. GINGF; Guanine Nucleotide Exchange Factor; HGF; Uncharacterized Protein SOS1; GF1; Alternate SOS1; Gingival Fibromatosis, Hereditary, 1; GGF1; Son Of Sevenless Homolog 1; NS4; SOS-1; SOS
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-184855
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

(S,S,S,S)-AHPC-Me is an E3 ligase ligand that can be used in research related to PROTAC synthesis, such as serving as the E3 ligase ligand for (4S)-PROTAC SOS1 degrader-1 (HY-144657) [1].
loading...
    loading...
Cat. No.: HY-182411
CAS No.: 2375482-34-9
Target:  

Ras PERK

Research Areas:  

Cancer

KRAS-IN-56 (Compound 18) is a KRAS inhibitor with an EC50 of 33 μM. KRAS-IN-56 inhibits the interaction between GTP-KRAS and SOS1. KRAS-IN-56 induces a decrease in p-ERK levels. KRAS-IN-56 can be used in research related to lung cancer [1].
loading...
    loading...
Cat. No.: HY-187998
CAS No.: 3034975-33-9
Target:  

Ras PERK

Research Areas:  

Cancer

AM-8719 is an orally active, blood-brain barrier-penetrant KRAS G12C inhibitor. AM-8719 binds covalently to KRAS G12C, inhibits SOS1-catalyzed GDP/GTP exchange, and suppresses downstream ERK phosphorylation. AM-8719 exhibits antiproliferative activity against KRAS G12C tumor cells. AM-8719 can be used for the research of KRAS G12C-positive cancers [1].
loading...
    loading...
Cat. No.: HY-163584
Target:  

PROTAC Linkers

Research Areas:  

Others

HOOC-Piperidine-CH2-3-azaspiro[5.5]undecane-Boc is a PROTAC linker that can be used for the synthesis of PROTACs, such as PROTAC SOS1 degrader-7 (HY-163582) [1].
loading...
    loading...
Cat. No.: HY-187519
Target:  

Ras

Research Areas:  

Cancer

KRAS-IN-61 is an orally effective pan-KRAS inhibitor that potently inhibits SOS1-mediated KRAS nucleotide exchange (IC50 <10 nM for KRAS G12D/G12V/G12C/WT). KRAS-IN-61 inhibits pERK signaling and cell proliferation in KRAS-mutant tumor cells. KRAS-IN-61 can inhibit tumor growth in vivo. KRAS-IN-61 can be used in studies of KRAS mutation-related cancers, such as colorectal cancer [1].
loading...
    loading...